Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 115 health care companies ranked by P/E ratio, at 4.9, followed by Universal Health Services (7.4) and Alnylam Pharmaceuticals (7.6). Figures as of 19 Nov 2026, 16:38 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- Lowest
- Edgewise Therapeutics4.9
- Median
- 30.4
- Combined market value
- ZAR 156.45T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.9 | ZAR 78.9B | ZAR 720.40 | 0.19% down | 86% up | ||
| 2 | Universal Health ServicesUHS · Health Care | 7.4 | ZAR 177.5B | ZAR 3,078.83 | 5.16% down | 17% down | ||
| 3 | Alnylam PharmaceuticalsALNY · Health Care | 7.6 | ZAR 349.6B | ZAR 2,609.94 | 0.13% up | 66% down | ||
| 4 | Tenet HealthcareTHC · Health Care | 7.7 | ZAR 365.8B | ZAR 4,596.48 | 2.91% down | 45% up | ||
| 5 | CVS HealthCVS · Health Care | 9.3 | ZAR 1.78T | ZAR 1,394.56 | 1.75% down | 7% up | ||
| 6 | Novo NordiskNVO · Health Care | 9.8 | ZAR 2.99T | ZAR 678.87 | 1.32% down | 17% down | ||
| 7 | GrifolsGRFS · Health Care | 10.0 | ZAR 98.3B | ZAR 144.46 | 2.24% down | 0% up | ||
| 8 | Bio-Rad LaboratoriesBIO · Health Care | 10.0 | ZAR 177B | ZAR 6,580.06 | 1.88% up | 22% up | ||
| 9 | DaVitaDVA · Health Care | 11.6 | ZAR 168.2B | ZAR 2,674.55 | 5.25% down | 40% up | ||
| 10 | Fresenius Medical CareFMS · Health Care | 11.6 | ZAR 182B | ZAR 350.60 | 4.08% down | 7% down | ||
| 11 | Cigna GroupCI · Health Care | 11.9 | ZAR 1.24T | ZAR 4,691.39 | 5.77% down | 6% up | ||
| 12 | Caris Life SciencesCAI · Health Care | 12.0 | ZAR 99.3B | ZAR 346.33 | 1.79% up | 19% down | ||
| 13 | Oscar HealthOSCR · Health Care | 12.0 | ZAR 146B | ZAR 469.85 | 2.32% down | 112% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | 12.9 | ZAR 2.08T | ZAR 1,018.22 | 2.01% down | 30% up | ||
| 15 | ZoetisZTS · Health Care | 14.0 | ZAR 584.1B | ZAR 1,437.48 | 3.72% down | 26% down | ||
| 16 | HCA HealthcareHCA · Health Care | 15.4 | ZAR 1.69T | ZAR 8,085.23 | 2.72% down | 0% up | ||
| 17 | Elevance HealthELV · Health Care | 16.4 | ZAR 1.46T | ZAR 6,752.09 | 3.45% down | 28% up | ||
| 18 | GSKGSK · Health Care | 16.7 | ZAR 1.68T | ZAR 835.64 | 1.41% down | 5% up | ||
| 19 | Globus MedicalGMED · Health Care | 17.1 | ZAR 160.7B | ZAR 1,212.76 | 1.45% down | 14% down | ||
| 20 | GE HealthCare TechnologiesGEHC · Health Care | 17.4 | ZAR 650.3B | ZAR 1,438.35 | 1.46% down | 12% up | ||
| 21 | Ascendis PharmaASND · Health Care | 17.5 | ZAR 304.6B | ZAR 4,643.24 | 1.55% down | 29% up | ||
| 22 | Boston ScientificBSX · Health Care | 18.3 | ZAR 1.09T | ZAR 755.20 | 0.81% down | 55% down | ||
| 23 | UnitedHealth GroupUNH · Health Care | 18.8 | ZAR 5.15T | ZAR 5,746.95 | 5.86% down | 12% up | ||
| 24 | CencoraCOR · Health Care | 19.0 | ZAR 1.13T | ZAR 5,938.17 | 2.29% down | 4% down | ||
| 25 | ExelixisEXEL · Health Care | 19.8 | ZAR 282.1B | ZAR 1,156.23 | 2.96% down | 63% up | ||
| 26 | Smith & NephewSNN · Health Care | 20.3 | ZAR 218B | ZAR 521.41 | 1.43% down | 5% down | ||
| 27 | Cooper CompaniesCOO · Health Care | 20.6 | ZAR 199.2B | ZAR 1,047.80 | 1.14% down | 15% down | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 20.7 | ZAR 1.69T | ZAR 16,362.48 | 0.81% down | 28% up | ||
| 29 | Encompass HealthEHC · Health Care | 21.0 | ZAR 224.2B | ZAR 2,284.54 | 2.96% down | 20% up | ||
| 30 | United TherapeuticsUTHR · Health Care | 21.4 | ZAR 422.1B | ZAR 9,910.22 | 1.62% down | 22% up | ||
| 31 | ResMedRMD · Health Care | 21.6 | ZAR 581.9B | ZAR 4,137.09 | 2.26% down | 1% down | ||
| 32 | CenteneCNC · Health Care | 22.2 | ZAR 558B | ZAR 1,127.18 | 4.22% down | 94% up | ||
| 33 | InsuletPODD · Health Care | 22.5 | ZAR 166.5B | ZAR 2,400.22 | 1.72% down | 55% down | ||
| 34 | MSA SafetyMSA · Health Care | 22.8 | ZAR 119.6B | ZAR 3,105.61 | 0.31% up | 16% up | ||
| 35 | SanofiSNY · Health Care | 22.9 | ZAR 1.93T | ZAR 802.57 | 2.38% down | 4% down | ||
| 36 | Option Care HealthOPCH · Health Care | 22.9 | ZAR 82.6B | ZAR 551.60 | 0.30% down | 12% up | ||
| 37 | Henry ScheinHSIC · Health Care | 23.1 | ZAR 163B | ZAR 1,474.21 | 1.39% down | 20% up | ||
| 38 | Halozyme TherapeuticsHALO · Health Care | 23.4 | ZAR 186.3B | ZAR 1,633.85 | 2.25% down | 39% up | ||
| 39 | Align TechnologyALGN · Health Care | 23.6 | ZAR 199.4B | ZAR 2,829.33 | 1.09% down | 23% up | ||
| 40 | Neurocrine BiosciencesNBIX · Health Care | 23.7 | ZAR 282B | ZAR 2,786.50 | 1.93% down | 17% up | ||
| 41 | PACS GroupPACS · Health Care | 24.1 | ZAR 117.7B | ZAR 741.42 | 8.22% down | 77% up | ||
| 42 | Concentra Group Holdings ParentCON · Health Care | 24.5 | ZAR 90.8B | ZAR 722.14 | 1.26% down | 116% up | ||
| 43 | MedtronicMDT · Health Care | 24.7 | ZAR 2.24T | ZAR 1,753.80 | 0.20% down | 1% up | ||
| 44 | AstraZenecaAZN · Health Care | 24.7 | ZAR 4.73T | ZAR 3,049.43 | 2.23% down | 1% up | ||
| 45 | Lantheus HoldingsLNTH · Health Care | 25.4 | ZAR 116.4B | ZAR 1,780.06 | 0.02% up | 90% up | ||
| 46 | Koninklijke PhilipsPHG · Health Care | 25.6 | ZAR 502.1B | ZAR 513.65 | 1.24% down | 12% up | ||
| 47 | AmgenAMGN · Health Care | 25.6 | ZAR 4.17T | ZAR 7,706.11 | 0.50% down | 32% up | ||
| 48 | Quest DiagnosticsDGX · Health Care | 25.9 | ZAR 499.3B | ZAR 4,538.12 | 0.16% up | 38% up | ||
| 49 | ChemedCHE · Health Care | 26.0 | ZAR 122.9B | ZAR 9,486.34 | 0.55% down | 27% up | ||
| 50 | Zimmer Biomet HoldingsZBH · Health Care | 26.0 | ZAR 340.6B | ZAR 1,799.51 | 0.17% down | 16% up | ||
| 51 | LivaNovaLIVN · Health Care | 26.6 | ZAR 89.1B | ZAR 1,617.80 | 1.92% down | 77% up | ||
| 52 | Ensign GroupENSG · Health Care | 26.6 | ZAR 182B | ZAR 3,119.40 | 2.29% down | 2% up | ||
| 53 | QiagenQGEN · Health Care | 26.8 | ZAR 178.8B | ZAR 865.73 | 0.12% up | 9% up | ||
| 54 | Protagonist TherapeuticsPTGX · Health Care | 26.8 | ZAR 144.6B | ZAR 2,215.28 | 0.15% down | 51% up | ||
| 55 | McKessonMCK · Health Care | 27.1 | ZAR 2.11T | ZAR 18,306.97 | 3.24% down | 28% up | ||
| 56 | NovartisNVS · Health Care | 28.9 | ZAR 4.98T | ZAR 2,638.90 | 2.55% down | 25% up | ||
| 57 | STERISSTE · Health Care | 30.2 | ZAR 430.7B | ZAR 4,435.79 | 2.05% down | 1% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.4 | ZAR 524.8B | ZAR 6,463.34 | 0.09% down | 42% up | ||
| 59 | AvantorAVTR · Health Care | 30.6 | ZAR 181.1B | ZAR 267.20 | 0.36% down | 40% up | ||
| 60 | IQVIA HoldingsIQV · Health Care | 31.2 | ZAR 737.5B | ZAR 4,474.87 | 0.53% down | 19% up | ||
| 61 | Merit Medical SystemsMMSI · Health Care | 31.7 | ZAR 88.4B | ZAR 1,476.13 | 1.54% down | 1% up | ||
| 62 | DexComDXCM · Health Care | 32.0 | ZAR 528.7B | ZAR 1,417.59 | 1.54% down | 41% up | ||
| 63 | argenxARGX · Health Care | 32.8 | ZAR 1.04T | ZAR 16,522.38 | 0.61% up | 2% up | ||
| 64 | StrykerSYK · Health Care | 33.4 | ZAR 2.09T | ZAR 5,477.13 | 1.33% down | 12% down | ||
| 65 | Vertex PharmaceuticalsVRTX · Health Care | 33.9 | ZAR 2.33T | ZAR 9,187.90 | 1.83% down | 27% up | ||
| 66 | HealthEquityHQY · Health Care | 34.9 | ZAR 139.4B | ZAR 1,684.88 | 0.76% down | 3% down | ||
| 67 | Agilent TechnologiesA · Health Care | 35.3 | ZAR 881B | ZAR 3,124.63 | 0.99% up | 22% up | ||
| 68 | Cardinal HealthCAH · Health Care | 35.4 | ZAR 1.1T | ZAR 4,774.09 | 1.69% down | 34% up | ||
| 69 | Medpace HoldingsMEDP · Health Care | 35.7 | ZAR 314.1B | ZAR 11,227.49 | 0.52% down | 10% up | ||
| 70 | IlluminaILMN · Health Care | 36.5 | ZAR 559B | ZAR 3,696.86 | 0.89% up | 76% up | ||
| 71 | Thermo Fisher ScientificTMO · Health Care | 36.9 | ZAR 4.52T | ZAR 12,190.84 | 0.86% up | 21% up | ||
| 72 | HumanaHUM · Health Care | 36.9 | ZAR 793.5B | ZAR 6,606.75 | 1.84% down | 73% up | ||
| 73 | Mettler-Toledo InternationalMTD · Health Care | 37.4 | ZAR 598.1B | ZAR 30,067.30 | 0.80% down | 24% up | ||
| 74 | DanaherDHR · Health Care | 37.8 | ZAR 2.8T | ZAR 3,980.94 | 0.18% down | 3% up | ||
| 75 | Abbott LaboratoriesABT · Health Care | 39.1 | ZAR 3.16T | ZAR 1,826.90 | 0.22% up | 16% down | ||
| 76 | PfizerPFE · Health Care | 39.6 | ZAR 2.75T | ZAR 483.29 | 1.28% down | 15% up | ||
| 77 | Johnson & JohnsonJNJ · Health Care | 40.4 | ZAR 11.17T | ZAR 4,639.58 | 2.49% down | 34% up | ||
| 78 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.3 | ZAR 216.1B | ZAR 259.18 | 0.83% down | 8% up | ||
| 79 | Becton, DickinsonBDX · Health Care | 42.0 | ZAR 1.01T | ZAR 3,707.02 | 1.67% down | 45% up | ||
| 80 | Krystal BiotechKRYS · Health Care | 43.0 | ZAR 163.6B | ZAR 5,521.88 | 0.36% up | 54% up | ||
| 81 | Eli LillyLLY · Health Care | 44.1 | ZAR 21.11T | ZAR 23,702.10 | 1.75% down | 33% up | ||
| 82 | GenmabGMAB · Health Care | 44.5 | ZAR 559.6B | ZAR 907.61 | 2.06% up | 70% up | ||
| 83 | Royalty PharmaRPRX · Health Care | 44.6 | ZAR 684.7B | ZAR 1,190.86 | 0.60% down | 79% up | ||
| 84 | West Pharmaceutical ServicesWST · Health Care | 44.9 | ZAR 486.6B | ZAR 6,984.84 | 0.91% down | 57% up | ||
| 85 | BrightSpring Health ServicesBTSG · Health Care | 46.5 | ZAR 227.5B | ZAR 1,143.49 | 4.10% down | 109% up | ||
| 86 | IDEXX LaboratoriesIDXX · Health Care | 46.7 | ZAR 951.7B | ZAR 12,079.62 | 0.88% down | 1% up | ||
| 87 | AbbVieABBV · Health Care | 48.5 | ZAR 8.7T | ZAR 4,920.65 | 1.39% down | 25% up | ||
| 88 | Corcept TherapeuticsCORT · Health Care | 49.6 | ZAR 126.1B | ZAR 1,151.87 | 2.61% down | 10% down | ||
| 89 | Intuitive SurgicalISRG · Health Care | 50.5 | ZAR 2.53T | ZAR 7,293.39 | 0.69% down | 24% down | ||
| 90 | BeOne MedicinesONC · Health Care | 51.8 | ZAR 804.6B | ZAR 7,043.81 | 0.03% up | 16% up | ||
| 91 | HaemoneticsHAE · Health Care | 53.2 | ZAR 95.6B | ZAR 2,098.38 | 2.11% down | 64% up | ||
| 92 | Amneal PharmaceuticalsAMRX · Health Care | 53.8 | ZAR 130.9B | ZAR 375.64 | 1.60% down | 90% up | ||
| 93 | AlconALC · Health Care | 55.0 | ZAR 631B | ZAR 1,313.52 | 0.03% up | 0% up | ||
| 94 | IncyteINCY · Health Care | 59.6 | ZAR 415.4B | ZAR 2,037.93 | 0.84% down | 16% up | ||
| 95 | Edwards LifesciencesEW · Health Care | 60.9 | ZAR 1.05T | ZAR 1,827.21 | 0.48% down | 25% up | ||
| 96 | Bio-TechneTECH · Health Care | 66.7 | ZAR 199.3B | ZAR 1,268.76 | 0.04% down | 24% up | ||
| 97 | HeartflowHTFL · Health Care | 69.0 | ZAR 70.9B | ZAR 806.41 | 0.72% up | 66% up | ||
| 98 | RevvityRVTY · Health Care | 69.3 | ZAR 303.9B | ZAR 2,721.77 | 2.34% up | 62% up | ||
| 99 | Jazz PharmaceuticalsJAZZ · Health Care | 71.2 | ZAR 269.5B | ZAR 4,198.16 | 2.89% down | 41% up | ||
| 100 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 72.2 | ZAR 130.6B | ZAR 1,662.72 | 0.26% up | 129% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4473 ZAR). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Universal Health Services (7.4) and Alnylam Pharmaceuticals (7.6) have the lowest P/E ratio of the 115 health care companies ranked here as of 19 Nov 2026, 16:38 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of ZAR 156.45T as of 19 Nov 2026, 16:38 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.